Global Hemophilia Management Market?Estimated to reach USD 5.62 billion by 2022Posted by rohan on February 7th, 2018 According to the report “Global Hemophilia Management Market,” published by Market Data Forecast, the global market is projected to reach USD 5.62 billion by 2022 from USD 161.4 billion in 20167 at a CAGR of 1.62% from 2017 to 2022 Hemophilia is a genetic disorder which impairs body`s ability to control blood clotting. Hemophilia usually occurs in males it is estimated that about 1 in 5000 males that are born each year contain hemophilia.Hemophilia is an inherited bleeding disorder which prevents blood clotting. People born with hemophilia have little or no clotting factor. Clotting factor is a protein needed for normal blood clotting. There are several types of clotting factors. These proteins work with platelets to help the blood clot. About 7 out of 10 people who have hemophilia A have the severe form of the disorder. People who don't have hemophilia have a factor VIII activity of 100 percent. People who have severe hemophilia A have a factor VIII activity of less than 1 percent. Hemophilia is categorized into three levels depending on its severity as severe, moderate and mild. About 80% of the hemophilia patients are considered to suffer from severe type. The worldwide incidence of hemophilia is estimated at more than 400,000 people. It is estimated that about 75% of the hemophilia patients do not receive adequate treatment. Get a comprehensive overview of the Global Hemophilia Management Market: http://www.marketdataforecast.com/market-reports/global-hemophilia-management-market-310/ Global Bio Hemophilia Management Market: Drivers & Restraints Growing prevalence of the disease and increasing usage of recombinant product is expected to drive the market growth. Technological advancements and advancements in the novel coagulating factors and are also fuelling the growth of global Hemophilia Management market. Rising investments in Research and developments for hemophilia products is also driving the market growth. However lack of available medication, awareness of this disease and high cost of treatment are the major restraining factors in the market. Advancements in gene therapy and increasing number of drug approvals for treatment of hemophilia provide immense growth opportunities in the market. Get accurate market forecast and analysis on the Global Hemophilia Management Market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/global-hemophilia-management-market-310/request-sample Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Like it? Share it! More by this author |